Stay updated on Pembrolizumab in Unresectable Squamous Skin Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Unresectable Squamous Skin Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Unresectable Squamous Skin Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error instead of the study content for NCT02883556, indicating the record is currently inaccessible.
    Difference
    18%
    Check dated 2026-09-19T20:48:32.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    An NIH grant/contract note for 2016 was added to the page, and the site revision was updated to v3.6.6 (replacing the previous v3.6.5).
    Difference
    0.1%
    Check dated 2026-08-29T22:00:46.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    Revision badge updated from v3.6.4 to v3.6.5, reflecting a minor deployment change. The study details themselves remain unchanged.
    Difference
    0.1%
    Check dated 2026-08-08T23:29:52.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Revision: v3.6.4 replaces the previous Revision: v3.6.3, signaling a minor update to the page template or content. It does not alter the study details or other user-facing information on the page.
    Difference
    0.1%
    Check dated 2026-07-25T16:54:54.000Z thumbnail image
  7. Check
    93 days ago
    Change Detected
    Summary
    A new Revision: v3.6.3 label was added to the page, replacing the previous v3.6.2 label.
    Difference
    0.1%
    Check dated 2026-07-04T08:16:18.000Z thumbnail image
  8. Check
    100 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.2, replacing the previous v3.6.0 label. This indicates a new deployment of the page without changes to study data.
    Difference
    0.1%
    Check dated 2026-06-27T03:59:59.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Unresectable Squamous Skin Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Unresectable Squamous Skin Cancer Clinical Trial page.